Trade alert for break above Point of Control (redline)
Earnings highlights
Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases.
Q4 GAAP EPS of -$0.08 in-line.
Revenue of $1.22M (-1.6% Y/Y) beats by $0.29M.
Earnings highlights
Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases.
Q4 GAAP EPS of -$0.08 in-line.
Revenue of $1.22M (-1.6% Y/Y) beats by $0.29M.